nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4D—adipose tissue—polycystic ovary syndrome	0.014	0.117	CbGeAlD
Roflumilast—PDE4D—adrenal gland—polycystic ovary syndrome	0.0126	0.105	CbGeAlD
Roflumilast—PDE4A—adipose tissue—polycystic ovary syndrome	0.0124	0.103	CbGeAlD
Roflumilast—PDE4D—female gonad—polycystic ovary syndrome	0.0117	0.0977	CbGeAlD
Roflumilast—PDE4A—adrenal gland—polycystic ovary syndrome	0.0111	0.0928	CbGeAlD
Roflumilast—PDE4A—female gonad—polycystic ovary syndrome	0.0104	0.0865	CbGeAlD
Roflumilast—Influenza—Metformin—polycystic ovary syndrome	0.00962	0.0431	CcSEcCtD
Roflumilast—Infestation NOS—Metformin—polycystic ovary syndrome	0.00858	0.0384	CcSEcCtD
Roflumilast—Infestation—Metformin—polycystic ovary syndrome	0.00858	0.0384	CcSEcCtD
Roflumilast—PDE4B—endometrium—polycystic ovary syndrome	0.00821	0.0684	CbGeAlD
Roflumilast—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00811	0.0363	CcSEcCtD
Roflumilast—Rhinitis—Metformin—polycystic ovary syndrome	0.00772	0.0346	CcSEcCtD
Roflumilast—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00757	0.0339	CcSEcCtD
Roflumilast—PDE4B—pituitary gland—polycystic ovary syndrome	0.00743	0.0619	CbGeAlD
Roflumilast—PDE4B—adipose tissue—polycystic ovary syndrome	0.0074	0.0617	CbGeAlD
Roflumilast—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00715	0.032	CcSEcCtD
Roflumilast—Immune system disorder—Metformin—polycystic ovary syndrome	0.00695	0.0312	CcSEcCtD
Roflumilast—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00694	0.0311	CcSEcCtD
Roflumilast—Malnutrition—Metformin—polycystic ovary syndrome	0.0067	0.03	CcSEcCtD
Roflumilast—PDE4B—adrenal gland—polycystic ovary syndrome	0.00663	0.0553	CbGeAlD
Roflumilast—Dysgeusia—Metformin—polycystic ovary syndrome	0.00656	0.0294	CcSEcCtD
Roflumilast—Muscle spasms—Metformin—polycystic ovary syndrome	0.00644	0.0289	CcSEcCtD
Roflumilast—Tremor—Metformin—polycystic ovary syndrome	0.00628	0.0281	CcSEcCtD
Roflumilast—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00622	0.0279	CcSEcCtD
Roflumilast—PDE4B—female gonad—polycystic ovary syndrome	0.00619	0.0516	CbGeAlD
Roflumilast—PDE4B—vagina—polycystic ovary syndrome	0.00615	0.0513	CbGeAlD
Roflumilast—Malaise—Metformin—polycystic ovary syndrome	0.00604	0.0271	CcSEcCtD
Roflumilast—Palpitations—Metformin—polycystic ovary syndrome	0.00592	0.0265	CcSEcCtD
Roflumilast—PDE4B—endocrine gland—polycystic ovary syndrome	0.00575	0.048	CbGeAlD
Roflumilast—Myalgia—Metformin—polycystic ovary syndrome	0.00571	0.0256	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00567	0.0254	CcSEcCtD
Roflumilast—Discomfort—Metformin—polycystic ovary syndrome	0.00564	0.0253	CcSEcCtD
Roflumilast—Infection—Metformin—polycystic ovary syndrome	0.00543	0.0244	CcSEcCtD
Roflumilast—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00536	0.024	CcSEcCtD
Roflumilast—Skin disorder—Metformin—polycystic ovary syndrome	0.00531	0.0238	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00498	0.0223	CcSEcCtD
Roflumilast—Dyspepsia—Metformin—polycystic ovary syndrome	0.00481	0.0216	CcSEcCtD
Roflumilast—Decreased appetite—Metformin—polycystic ovary syndrome	0.00475	0.0213	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00472	0.0212	CcSEcCtD
Roflumilast—Fatigue—Metformin—polycystic ovary syndrome	0.00472	0.0211	CcSEcCtD
Roflumilast—Constipation—Metformin—polycystic ovary syndrome	0.00468	0.021	CcSEcCtD
Roflumilast—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00451	0.0202	CcSEcCtD
Roflumilast—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00447	0.02	CcSEcCtD
Roflumilast—Urticaria—Metformin—polycystic ovary syndrome	0.00435	0.0195	CcSEcCtD
Roflumilast—Abdominal pain—Metformin—polycystic ovary syndrome	0.00432	0.0194	CcSEcCtD
Roflumilast—Asthenia—Metformin—polycystic ovary syndrome	0.00392	0.0176	CcSEcCtD
Roflumilast—Diarrhoea—Metformin—polycystic ovary syndrome	0.00374	0.0168	CcSEcCtD
Roflumilast—Dizziness—Metformin—polycystic ovary syndrome	0.00362	0.0162	CcSEcCtD
Roflumilast—Vomiting—Metformin—polycystic ovary syndrome	0.00348	0.0156	CcSEcCtD
Roflumilast—Rash—Metformin—polycystic ovary syndrome	0.00345	0.0155	CcSEcCtD
Roflumilast—Dermatitis—Metformin—polycystic ovary syndrome	0.00345	0.0154	CcSEcCtD
Roflumilast—Headache—Metformin—polycystic ovary syndrome	0.00343	0.0154	CcSEcCtD
Roflumilast—Nausea—Metformin—polycystic ovary syndrome	0.00325	0.0146	CcSEcCtD
Roflumilast—PDE4D—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00125	0.00191	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00125	0.0019	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00123	0.00188	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00123	0.00187	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00123	0.00187	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NPB—polycystic ovary syndrome	0.00123	0.00187	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00123	0.00187	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00122	0.00185	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00121	0.00185	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00121	0.00184	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.0012	0.00183	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00119	0.00182	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00119	0.00181	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00118	0.0018	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00118	0.00179	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00117	0.00179	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00117	0.00178	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00116	0.00177	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00116	0.00177	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00116	0.00177	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00115	0.00175	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00114	0.00173	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00112	0.00171	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00112	0.0017	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00112	0.0017	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00111	0.00169	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00111	0.00169	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00111	0.00169	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—LHB—polycystic ovary syndrome	0.0011	0.00168	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00109	0.00166	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00109	0.00165	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00108	0.00164	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00107	0.00163	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00107	0.00162	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00106	0.00161	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00105	0.00159	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00104	0.00158	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00103	0.00158	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00103	0.00156	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00102	0.00156	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00102	0.00156	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00101	0.00153	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INHBB—polycystic ovary syndrome	0.001	0.00152	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000987	0.0015	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000978	0.00149	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000978	0.00149	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000958	0.00146	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000953	0.00145	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000951	0.00145	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000935	0.00142	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00093	0.00142	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00092	0.0014	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000912	0.00139	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000905	0.00138	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000895	0.00136	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00089	0.00135	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000882	0.00134	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FST—polycystic ovary syndrome	0.000872	0.00133	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000868	0.00132	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000867	0.00132	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000861	0.00131	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000851	0.0013	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000851	0.0013	CbGpPWpGaD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	0.000835	0.00127	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000832	0.00127	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000828	0.00126	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000823	0.00125	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00081	0.00123	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000805	0.00123	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000804	0.00122	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000803	0.00122	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000801	0.00122	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000797	0.00121	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000788	0.0012	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000787	0.0012	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000779	0.00119	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000762	0.00116	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000761	0.00116	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FST—polycystic ovary syndrome	0.000759	0.00116	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000755	0.00115	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00075	0.00114	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00075	0.00114	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000748	0.00114	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000741	0.00113	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000741	0.00113	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LHB—polycystic ovary syndrome	0.000741	0.00113	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	0.000735	0.00112	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00073	0.00111	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000729	0.00111	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000724	0.0011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FST—polycystic ovary syndrome	0.000722	0.0011	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000718	0.00109	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000714	0.00109	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000705	0.00107	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000705	0.00107	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000701	0.00107	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0007	0.00107	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SCT—polycystic ovary syndrome	0.000694	0.00106	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000692	0.00105	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000689	0.00105	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000686	0.00104	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000685	0.00104	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000683	0.00104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FST—polycystic ovary syndrome	0.000668	0.00102	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000667	0.00102	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000666	0.00101	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000665	0.00101	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000662	0.00101	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000661	0.00101	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00066	0.00101	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000653	0.000993	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000652	0.000993	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000652	0.000993	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000651	0.000991	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000645	0.000982	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000638	0.000971	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000635	0.000967	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00063	0.00096	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00062	0.000944	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000619	0.000943	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000618	0.00094	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000616	0.000938	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000614	0.000935	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000611	0.000931	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00061	0.000929	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000605	0.000921	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000604	0.00092	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000604	0.000919	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000602	0.000917	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000594	0.000905	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000583	0.000888	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000573	0.000873	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000573	0.000873	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000568	0.000865	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INSR—polycystic ovary syndrome	0.000568	0.000865	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000566	0.000861	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000562	0.000855	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000562	0.000855	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00056	0.000852	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000541	0.000824	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000541	0.000823	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00054	0.000822	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000536	0.000816	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000531	0.000809	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000531	0.000808	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PGR—polycystic ovary syndrome	0.000526	0.000801	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000523	0.000797	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000523	0.000796	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00052	0.000792	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000514	0.000782	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000506	0.00077	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000501	0.000762	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INSR—polycystic ovary syndrome	0.0005	0.000762	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000495	0.000753	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000491	0.000748	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRL—polycystic ovary syndrome	0.00049	0.000746	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000489	0.000744	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000489	0.000744	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000475	0.000724	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000472	0.000719	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000471	0.000717	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000468	0.000712	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000467	0.00071	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000466	0.000709	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000466	0.000709	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000465	0.000708	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000463	0.000705	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000455	0.000693	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000453	0.000689	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000448	0.000683	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000444	0.000676	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000433	0.000659	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000431	0.000656	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000431	0.000656	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000431	0.000656	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000431	0.000656	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000431	0.000655	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000428	0.000651	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRL—polycystic ovary syndrome	0.000427	0.00065	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000415	0.000632	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000411	0.000626	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000411	0.000626	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000411	0.000625	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00041	0.000624	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000407	0.00062	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000406	0.000618	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000405	0.000616	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000403	0.000614	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000401	0.00061	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000399	0.000607	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000391	0.000596	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000385	0.000587	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000379	0.000577	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000377	0.000574	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000376	0.000572	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000375	0.000571	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000362	0.000551	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000358	0.000544	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000357	0.000544	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000357	0.000543	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000351	0.000534	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000345	0.000526	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00034	0.000518	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LEP—polycystic ovary syndrome	0.000338	0.000514	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000334	0.000509	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000331	0.000503	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000315	0.000479	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000309	0.000471	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000301	0.000459	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000301	0.000458	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LEP—polycystic ovary syndrome	0.000294	0.000448	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—polycystic ovary syndrome	0.00029	0.000442	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INS—polycystic ovary syndrome	0.000289	0.00044	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000286	0.000436	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LEP—polycystic ovary syndrome	0.00028	0.000426	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000279	0.000425	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000279	0.000425	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000265	0.000404	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000265	0.000403	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000262	0.0004	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000259	0.000394	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—polycystic ovary syndrome	0.000253	0.000385	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INS—polycystic ovary syndrome	0.000251	0.000383	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00025	0.00038	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000243	0.00037	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000243	0.00037	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000241	0.000366	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INS—polycystic ovary syndrome	0.000239	0.000364	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000231	0.000352	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000231	0.000352	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000231	0.000352	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000231	0.000351	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—polycystic ovary syndrome	0.000223	0.000339	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INS—polycystic ovary syndrome	0.000221	0.000337	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00022	0.000335	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000214	0.000326	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000214	0.000326	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000214	0.000325	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000203	0.00031	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000186	0.000283	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000182	0.000278	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000177	0.000269	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000164	0.000249	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000159	0.000242	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000151	0.00023	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.00014	0.000213	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—polycystic ovary syndrome	0.000126	0.000192	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—polycystic ovary syndrome	0.00011	0.000167	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—polycystic ovary syndrome	0.000105	0.000159	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—polycystic ovary syndrome	9.67e-05	0.000147	CbGpPWpGaD
